pancreatitis from semaglutide A 54-year-old woman with obesity (BMI 38 kg/m²) and type 2 diabetes is being considered for semaglutide. Five years ago she developed acute secondary to gallstones. She underwent laparoscopic cholecystectomy and Does Semaglutide Cause Pancreatitis? Evidence

The situation is causing the FDA regulatory headaches and, more seriously, posing potential risks to the public.

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish drugmaker Novo Nordisk that should expand access to its in-demand GLP-1 at the expense of Eli Lillys.

These medications pose serious health risks due to lack of FDA approval and regulation.

Question: I always thought you billed Z79.899 whenever a patient was taking a long-term medication that does not have a more specific code, such as insulin, warfarin, metformin, and so on

Newer GLP-1 therapies are redefining whats possible in medical weight loss. Retatrutide is a next-generation triple-agonist GLP-1...